BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31409891)

  • 1. SnoN residue (1-366) attenuates hypertrophic scars through resistance to transforming growth factor-β1-induced degradation.
    Sun GF; Li HC; Zhan YP; Zhang XF; Pan LY; Chen YF; Xu K; Feng DX
    Lab Invest; 2019 Dec; 99(12):1861-1873. PubMed ID: 31409891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loureirin B inhibits fibroblast proliferation and extracellular matrix deposition in hypertrophic scar via TGF-β/Smad pathway.
    Bai X; He T; Liu J; Wang Y; Fan L; Tao K; Shi J; Tang C; Su L; Hu D
    Exp Dermatol; 2015 May; 24(5):355-60. PubMed ID: 25683490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smad interacting protein 1 influences transforming growth factor-β
    Fang X; Hu X; Zheng Z; Tao K; Wang H; Guan H; Shi J; Ji P; Cai W; Bai X; Zhu X; Han J; Liu J; Hu D
    J Mol Histol; 2019 Dec; 50(6):503-514. PubMed ID: 31595443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of TRAP-1-like protein (TLP) gene on collagen synthesis induced by TGF-β/Smad signaling in human dermal fibroblasts.
    Wang X; Qian Y; Jin R; Wo Y; Chen J; Wang C; Wang D
    PLoS One; 2013; 8(2):e55899. PubMed ID: 23418473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corilagin alleviates hypertrophic scars via inhibiting the transforming growth factor (TGF)-β/Smad signal pathway.
    Li Y; Yu Z; Zhao D; Han D
    Life Sci; 2021 Jul; 277():119483. PubMed ID: 33862115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of mechanical tension on the formation of hypertrophic scars in rabbit ears and transforming growth factor-β
    Cao P; Wang YW; Guan H; Yang YS; Li SH; Chen Y; Zhu C; Wan Y; Ren LY; Yao M
    Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2022 Dec; 38(12):1162-1169. PubMed ID: 36594147
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of Pathological Phenotype of Hypertrophic Scar Fibroblasts Via Coculture with Adipose-Derived Stem Cells.
    Deng J; Shi Y; Gao Z; Zhang W; Wu X; Cao W; Liu W
    Tissue Eng Part A; 2018 Mar; 24(5-6):382-393. PubMed ID: 28562226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing NLRC5 inhibits extracellular matrix expression in keloid fibroblasts via inhibition of transforming growth factor-β1/Smad signaling pathway.
    Ma HL; Zhao XF; Chen GZ; Fang RH; Zhang FR
    Biomed Pharmacother; 2016 Oct; 83():1016-1021. PubMed ID: 27525969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALA-PDT promotes the death and contractile capacity of hypertrophic scar fibroblasts through inhibiting the TGF-β1/Smad2/3/4 signaling pathway.
    Qu Z; Chen Y; Du K; Qiao J; Chen L; Chen J; Wei L
    Photodiagnosis Photodyn Ther; 2024 Feb; 45():103915. PubMed ID: 38128289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smad ubiquitination regulatory factor 2 expression is enhanced in hypertrophic scar fibroblasts from burned children.
    Zhang Z; Finnerty CC; He J; Herndon DN
    Burns; 2012 Mar; 38(2):236-46. PubMed ID: 21920670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt4 negatively regulates the TGF-β1-induced human dermal fibroblast-to-myofibroblast transition via targeting Smad3 and ERK.
    Liu J; Zhao B; Zhu H; Pan Q; Cai M; Bai X; Li X; Hu X; Zhang M; Shi J; Zheng Z; Yang A; Hu D
    Cell Tissue Res; 2020 Mar; 379(3):537-548. PubMed ID: 31776823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The expression of SnoN in human hypertrophic scar fibroblasts and the mechanism of its participation in hypertrophic scar formation].
    Kuang F; Zhang Z; Chen B; Liu CL; Zhao YY; Xu ZR; Li XJ
    Zhonghua Shao Shang Za Zhi; 2017 Oct; 33(10):634-638. PubMed ID: 29056026
    [No Abstract]   [Full Text] [Related]  

  • 13. Knockdown of lysyl oxidase like 1 inhibits the proliferation and pro-fibrotic effects of transforming growth factor-β1-induced hypertrophic scar fibroblasts.
    Ying M; Chen Y; Yuan B
    Can J Physiol Pharmacol; 2021 Dec; 99(12):1272-1279. PubMed ID: 34283938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ellagic acid inhibits the formation of hypertrophic scars by suppressing TGF-β/Smad signaling pathway activity.
    Zhao ZJ; Wu DJ; Lv DL; Zhang BD; Chen L; Sun YQ
    Chem Biol Drug Des; 2023 Oct; 102(4):773-781. PubMed ID: 37386691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shikonin reduces TGF-β1-induced collagen production and contraction in hypertrophic scar-derived human skin fibroblasts.
    Fan C; Dong Y; Xie Y; Su Y; Zhang X; Leavesley D; Upton Z
    Int J Mol Med; 2015 Oct; 36(4):985-91. PubMed ID: 26239419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of silencing Smad ubiquitination regulatory factor 2 on the function of human hypertrophic scar-derived fibroblasts].
    Zhang Z; Kuang F; Liu CL; Chen B; Tang WB; Li XJ
    Zhonghua Shao Shang Za Zhi; 2017 Mar; 33(3):145-151. PubMed ID: 28316163
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression of Smad protein by normal skin fibroblasts and hypertrophic scar fibroblasts in response to transforming growth factor beta1.
    Xie JL; Qi SH; Pan S; Xu YB; Li TZ; Liu XS; Liu P
    Dermatol Surg; 2008 Sep; 34(9):1216-24; discussion 1224-5. PubMed ID: 18616749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of SnoN expression in obstructive nephropathy is mediated by an enhanced ubiquitin-dependent degradation.
    Tan R; Zhang J; Tan X; Zhang X; Yang J; Liu Y
    J Am Soc Nephrol; 2006 Oct; 17(10):2781-91. PubMed ID: 16959829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SKIL/SnoN attenuates TGF-β1/SMAD signaling-dependent collagen synthesis in hepatic fibrosis.
    Chi C; Liang X; Cui T; Gao X; Liu R; Yin C
    Biomol Biomed; 2023 Nov; 23(6):1014-1025. PubMed ID: 37389959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LY2109761 reduces TGF-β1-induced collagen production and contraction in hypertrophic scar fibroblasts.
    Wei G; Xu Q; Liu L; Zhang H; Tan X; Zhang C; Han C; Guo Y; Han G; Zhang C
    Arch Dermatol Res; 2018 Oct; 310(8):615-623. PubMed ID: 30046895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.